SUZUKEN : Notice Regarding Result of Acquisition of Treasury Shares by Own Share Repurchase Trading (ToSTNeT-3) and Completion of Treasury Share Acquisition
June 01, 2017 at 08:11 pm EDT
Share
Press Release Suzuken Co., Ltd.
Hiromi Miyata, President and CEO (Stock Code: 9987)
May 16, 2017
Securities Traded: First Sections of the Tokyo and Nagoya Stock Exchanges and the Sapporo Securities Exchange
Contact: Shigeru Asano, Director and Senior Executive Officer; Senior General Manager, Corporate Management Headquarters
Tel.: +81-52-961-2331
Notice Regarding Result of Acquisition of Treasury Shares by Own Share Repurchase Trading (ToSTNeT-3) and Completion of Treasury Share Acquisition
Suzuken Co., Ltd. (hereinafter "the Company") announced today that it conducted purchasing for the acquisition of treasury shares announced yesterday (May 15, 2017). The Company also announced that this has completed the acquisition of treasury shares in accordance with a resolution adopted by a meeting of the Board of Directors held on May 11, 2017.
Reason for Acquisition of Treasury Shares
To execute agile capital policies in response to changes in the economic environment.
Acquisition Details
Type of Shares Acquired Shares of common stock
Number of Shares Acquired 1,931,800 shares
Acquisition Price ¥3,570 per share
Total Amount of Acquisition Price ¥6,896,526,000
Acquisition Date May 16, 2017
Method of Acquisition Acquisition through Tokyo Stock Exchange Inc.'s own share
repurchase trading (ToSTNeT-3)
(Reference) Details of Resolution to Acquire Treasury Shares (Announced on May 11, 2017)
Type of Shares to Be Acquired Shares of common stock
Number of Shares to Be Acquired 2,200,000 shares (upper limit)
(Ratio of total number of issued shares (excluding treasury shares) 2.28%)
Total Amount of the Acquisition Price of the Shares ¥8.5 billion (upper limit)
Suzuken Co. Ltd. published this content on 16 May 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 02 June 2017 00:11:20 UTC.
Original documenthttp://v4.eir-parts.net/v4Contents/View.aspx?template=announcement&sid=36335&code=9987
Public permalinkhttp://www.publicnow.com/view/3E127BDB1F71DB1860F0935F7811443A121671E6
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
SUZUKEN : Notice Regarding Result of Acquisition of Treasury Shares by Own Share Repurchase Trading (ToSTNeT-3) and Completion of Treasury Share Acquisition